Advertisement

Animal Models of Geriatric Cognitive Dysfunction: Evidence for an Important Cholinergic Involvement

  • R. L. Dean
  • R. T. Bartus
Part of the Advances in Applied Neurological Sciences book series (NEUROLOGICAL, volume 2)

Abstract

Cognitive impairments in the aged present an increasingly important health problem. More than 11% of the U.S. population is 65 years of age or older, and many of these people suffer some degree of intellectual dysfunction. In 1.5–3 million people, this cognitive decline is greatly exacerbated by the presence of senile dementia of the Alzheimer’s type (SDAT). SDAT insidiously destroys the intellectual capacity of its victims (Reisberg et al. 1982), ultimately necessitating complete and perpetual institutional care. Annual costs for treatment and care are in excess of 20 billion dollars in the United States. At the same time, the devastating emotional burden and personal loss felt by family members, friends, and the patients themselves cannot be properly represented in financial terms. Improvement in other health care areas has been and is expected to continue to expand rapidly the aged sector of the population. The present magnitude of the health care problem posed by the elderly and clear projections for its increased incidence in the future demand a concerted efford to determine the nature, etiology, and treatment of cognitive impairments in the aged.

Keywords

Retention Interval Nonhuman Primate Basal Forebrain Senile Dementia Neurobiol Aging 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bartus RT (1978) Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: effects of concurrent administration of physostigmine and methylphenidate with scopolamine. Pharmacol Biochem Behav 9: 833–836PubMedCrossRefGoogle Scholar
  2. Bartus RT (1979 a) Effects of aging on visual memory, sensory processing and discrimination learning in the non-human primate. In: Ordy JM, Brizzee K (eds) Sensory systems and communication in the elderly. Raven, New York, pp 85–114 (Aging, vol 10)Google Scholar
  3. Bartus RT (1976b) Physostigmine and recent memory: effects in young and aged non-human primates. Science 206: 1087–1089CrossRefGoogle Scholar
  4. Bartus RT (1980) Cholinergic drug effects on memory and cognition in animals. In: Poon LW (ed) Aging in the 1980’s: psychological issues. American Psychological Association, Washington DC, pp 163–180CrossRefGoogle Scholar
  5. Bartus RT, Dean RL (1979) Recent memory in aged non-human primates: hypersensitivity to visual interference during retention. Exp Aging Res 5: 385–400PubMedCrossRefGoogle Scholar
  6. Bartus RT, Dean RL (1981) Age-related memory loss and drug therapy: possible directions based on animal models. In: Enna SJ, Samorajski T, Beer B (eds) Brain neurotransmitters and receptors in aging and age-related disorders. Raven, New York, pp 209–224 (Aging, vol 17 )Google Scholar
  7. Bartus RT, Johnson HR (1976) Short-term memory in the rhesus monkey: disruption from the anticholinergic scopolamine. Pharmacol Biochem Behav 5: 39–46PubMedCrossRefGoogle Scholar
  8. Bartus RT, Fleming D, Johnson HR (1978) Aging in the rhesus monkey: debilitating effects on short-term memory. J Gerontol 33: 858–871PubMedGoogle Scholar
  9. Bartus RT, Dean RL, Fleming DL (1979) Aging in the rhesus monkey: effects on visual discrimination learning and reversal learning. J Gerontol 34: 209–219PubMedGoogle Scholar
  10. Bartus RT, Dean RL, Beer B (1980) Memory deficits in aged Cebus monkeys and facilitation with central cholinomimetics. Neurobiol Aging 1: 145–152CrossRefGoogle Scholar
  11. Bartus RT, Dean RL, Beer B (1982 a) Neuropeptide effects on memory in aged monkeys. Neurobiol Aging 3:61–68CrossRefGoogle Scholar
  12. Bartus RT, Dean RL, Beer B, Lippa AS (1982 b) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417PubMedCrossRefGoogle Scholar
  13. Bartus RT, Dean RL, Beer B ( 1983 a) An evaluation of drugs for improving memory in aged monkeys: Implications for clinical trials in humans. Psychopharmacol Bull 19: 168–184Google Scholar
  14. Bartus RT, Flicker C, Dean RL ( 1983 b) Logical principles for the development of animal models of age-related memory impairments. In: Crook T, Ferris S, Bartus RT (eds) Assessment for geriatric psychopharmacology. Powley, New Canaan, CT, pp 263–299Google Scholar
  15. Bondareff W, Mountjoy CO, Roth M (1981) Selective loss of neurons of origin of adrenergic projection to cerebral cortex (locus coeruleus) in senile dementia. Lancet I 783–784CrossRefGoogle Scholar
  16. Botwinick J (1973) Aging and behavior. Springer, New YorkGoogle Scholar
  17. Brizzee KR, Ordy JM, Bartus RT (1980) Localization of cellular changes within multimodal sensory regions in aged monkey brain: possible implications for age-related cognitive loss. Neurobiol Aging 1: 45–52PubMedCrossRefGoogle Scholar
  18. Canestrari RE (1963) Paced and self-paced learning in young and elderly adults. J Gerontol 18: 165–168PubMedGoogle Scholar
  19. Christie JE, Shering A, Ferguson J, Glen AIM (1981) Physostigmine and arecoline: effects of in-travenous infusions in Alzheimer’s presenile dementia. Br J Psychiatry 128: 46–50CrossRefGoogle Scholar
  20. Coyle JT, Price DL, Delong MR (1983) Alzheimer’s disease: A disorder of cortical cholinergic innervation. Science 219: 1184–1190PubMedCrossRefGoogle Scholar
  21. Craik FIM (1977) Age-related differences in human memory. In: Birren JE, Schaie KW (eds) Handbook of the psychology of aging. Van Nostrand Reinhold, New York, pp 384–420Google Scholar
  22. Davies P (1981) Theoretical treatment possibilities for dementia of the Alzheimer’s type: the cholinergic hypothesis. In: Crook T, Gershon S (eds) Strategies for the development of an effective treatment for senile dementia. Powley, New Canaan, CT, pp 19–32Google Scholar
  23. Davis KL, Mohs RC, Tinklenberg JR (1979) Enhancement of memory by physostigmine. N Eng J Med 301: 946Google Scholar
  24. Dean RL, Scozzafava J, Goas JA, Regan B, Beer B, Bartus RT (1981) Age-related differences in behavior across the life span of the C57B1/6j mouse. Exp Aging Res 7: 427–451PubMedCrossRefGoogle Scholar
  25. Drachman DA (1977) Memory and cognitive function in man: does the cholinergic system have a specific role? Neurology 27: 783–790PubMedGoogle Scholar
  26. Drachman DA, Leavitt J (1974) Human memory and the cholinergic system: a relationship to aging. Arch Neurology 30: 113–121Google Scholar
  27. Flicker C, Dean RL, Watkins DL, Fisher SK, Bartus RT (1983) Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat. Pharmacol Biochem Behav 18: 973–981PubMedCrossRefGoogle Scholar
  28. Flicker C, Ferris SF, Bartus RT, Crook T (1984) Effects of aging and dementia upon recent visuospatial memory. Neurobiol Aging 5: 75–83CrossRefGoogle Scholar
  29. Gold PE, McGaugh JL (1975) Changes in learning and memory during aging. In: Ordy JM, Brizzee KR (eds) Neurobiology of aging. Plenum, New York, pp 53–57Google Scholar
  30. Gottfries CG (1982) The metabolism of some neurotransmitters in aging and dementia disorders. Gerontology 28 (2): 11–19PubMedCrossRefGoogle Scholar
  31. Kubanis P, Zornetzer SF (1981) Age-related behavioral and neurobiological changes: a review with emphasis on memory. Behav Neural Biol 31: 115–172PubMedCrossRefGoogle Scholar
  32. Lippa AS, Pelham RW, Beer B, Critchett DJ, Dean RL, Bartus RT (1980) Brain cholinergic dysfunction and memory in aged rats. Neurobiol Aging 1: 13–19PubMedCrossRefGoogle Scholar
  33. Lippa AS, Critchett DJ, Ehlert F, Yamamura HI, Enna SJ, Bartus RT (1981) Age-related alterations in neurotransmitter receptors: an electrophysiological and biochemical analysis. Neurobiol Aging 2: 3–8PubMedCrossRefGoogle Scholar
  34. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978) Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2: 1457–1459PubMedCrossRefGoogle Scholar
  35. Reisberg B, Ferris SH, Crook T (1982) Signs, symptoms and course of age-associated cognitive decline. In: Corkin S, Davis KL, Growdon JH, Usdin E, Wurtman RJ (eds) Alzheimer’s disease: a report of progress in research. Raven, New York, pp 177–182 (Aging, vol 19 )Google Scholar
  36. Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M (1984) Neurochemical characteristics of early and late onset types of Alzheimer’s disease. Br Med J 288: 961–964CrossRefGoogle Scholar
  37. Sherman KA, Kuster JE, Dean RL, Bartus RT, Friedman E (1981) Presynaptic cholinergic mechanisms in brain of aged rats with memory impairments. Neurobiol Aging 2: 99–104PubMedCrossRefGoogle Scholar
  38. Strong R, Hicks P, Hsu L, Bartus RT, Enna SJ (1980) Age-related alterations in the rodent brain cholinergic system and behavior. Neurobiol Aging 1: 59–63PubMedCrossRefGoogle Scholar
  39. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR (1982) Alzheimer’s disease and senile dementia: loss of neurons in the basal forebrain. Science 215: 1237–1239PubMedCrossRefGoogle Scholar
  40. Wilcock GK, Esiri MM, Bowen DM, Smith CCT (1982) Alzheimer’s disease: correlation of cortical choline acetyltransferase activity with severity of dementia and histological abnormalities. J Neurol Sci 57: 407–417PubMedCrossRefGoogle Scholar
  41. Zornetzer SF, Thompson R, Rogers J (1982) Rapid forgetting in aged rats. Behav Neural Biol 36: 49–60PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • R. L. Dean
  • R. T. Bartus
    • 1
    • 2
  1. 1.Dept. of CNS Research, Lederle Laboratories, Medical Research DivisionAmerican Cyanamid CompanyPearl RiverUSA
  2. 2.New York University Medical CenterNew York UniversityNew YorkUSA

Personalised recommendations